Proteomics

Dataset Information

0

Immunopeptidomics by use of a microfluidics chip.

ABSTRACT: A microfluidics technology was implemented to the immunoaffinity purification process of MHC peptides in Ligandomics/Immunopeptidomics. The thus purified HLA peptides were analysed by LCMS with the nanoElute LC and TimsTOF Pro Mass Spectrometer from Bruker. The aim of the microfluidics implementation was to improve the sensitivity and robustness while also reducing antibody and other material requirements in the immunoaffinity purification protocol.

INSTRUMENT(S): timsTOF Pro

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Ovary, B Cell, Bladder, Kidney

DISEASE(S): Ovarian Cancer,Urinary Bladder Cancer,Renal Cell Carcinoma

SUBMITTER: Rui Branca  

LAB HEAD: Janne Lehtio

PROVIDER: PXD022194 | Pride | 2022-02-17

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
Karita_Sara_Ligandome_20200421_human-JY-1E6-R1.zip Other
Karita_Sara_Ligandome_20200421_human-JY-1E6-R2.zip Other
Karita_Sara_Ligandome_20200421_human-JY-1E7-R1.zip Other
Karita_Sara_Ligandome_20200421_human-JY-1E7-R2.zip Other
Sara_20200213_Ligandome_JYchip_r1.zip Other
Items per page:
1 - 5 of 31
altmetric image

Publications

Identification of HLA class I ligands from the tumor surface (ligandome or immunopeptidome) is essential for designing T-cell mediated cancer therapeutic approaches. However, the sensitivity of the process for isolating MHC-I restricted tumor-specific peptides has been the major limiting factor for reliable tumor antigen characterization, making clear the need for technical improvement. Here, we describe our work from the fabrication and development of a microfluidic-based chip (PeptiCHIP) and i  ...[more]

Similar Datasets

Proteomics Exploiting trogocytosis by Immunopeptidomics to profile tumor associated antigens (TAA) actively targeted by tumor specific T cells in leukemia.
2023-09-07 | PXD035344 | Pride
Proteomics Iimmunopeptidomics pipeline for generation of personalized oncolytic cancer vaccines.
2022-04-06 | PXD026463 | Pride
Proteomics Immunopeptidomics of malignant mesothelioma to identify target antigens for T cell Immunotherapy
2023-09-08 | PXD038273 | Pride
Proteomics Ubiquitin-specific proximity labeling for the identification of E3 ubiquitin ligase substrates
2024-03-20 | PXD042702 | Pride
Proteomics Ubiquitin-specific proximity labeling for the identification of E3 ubiquitin ligase substrates
2024-03-20 | PXD042700 | Pride
Proteomics Ubiquitin-specific proximity labeling for the identification of E3 ubiquitin ligase substrates
2024-03-20 | PXD042698 | Pride
Proteomics The GlycoPaSER prototype as a real-time N-glycopeptide identification tool based on the PaSER parallel computing platform
2023-03-13 | PXD040716 | Pride
Proteomics Ubiquitin-specific proximity labeling for the identification of E3 ubiquitin ligase substrates
2024-03-20 | PXD047455 | Pride
Proteomics Continuous evolution of compact protein degradation tags regulated by selective cereblon molecular glues
2024-08-09 | PXD047665 | Pride
Proteomics Continuous evolution of compact protein degradation tags regulated by selective cereblon molecular glues
2024-08-09 | PXD047593 | Pride